MicroRNA-146a and human disease

Scandinavian Journal of Immunology

Volumn 71, Issue 4, 2010, Pages 227-231

  Li, L ^a   Chen, X P ^a   Li, Y J ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BIOLOGICAL MARKER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; METHOTREXATE; MICRORNA; MICRORNA 146A; MICRORNA 155; MICRORNA 18A; MICRORNA 193A; MICRORNA 29A; MICRORNA 92A; NUMB PROTEIN; PREDNISONE; RETINOIC ACID INDUCIBLE PROTEIN I; RNA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

5Q- SYNDROME; AUTOIMMUNE DISEASE; BREAST CANCER; CARCINOGENESIS; COLON ADENOMA; COLORECTAL CANCER; CORONARY ARTERY DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DRUG MECHANISM; DRUG RESPONSE; ENZYME INHIBITION; EPSTEIN BARR VIRUS; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLAMMATORY DISEASE; INNATE IMMUNITY; LEUKEMIA; MALIGNANT TRANSFORMATION; METASTASIS; METASTASIS INHIBITION; MUSCLE DISEASE; NEGATIVE FEEDBACK; NONHUMAN; PATHOPHYSIOLOGY; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; RNA SYNTHESIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION; VIRUS REPLICATION;

HUMANS; IMMUNE SYSTEM DISEASES; MICRORNAS; TUMOR MARKERS, BIOLOGICAL;

EID: 77949995894     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2010.02383.x     Document Type: Review

References (53)

1. Ambros V. The functions of animal microRNAs. Nature 2004 431 : 350 355.
2. Cordes KR, Sheehy NT, White MP et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009 460 : 705 711.
3. Gangaraju VK, Lin H. MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol 2009 10 : 116 125.
4. Asli NS, Pitulescu ME, Kessel M. MicroRNAs in organogenesis and disease. Curr Mol Med 2008 8 : 698 710.
5. Yang B, Lin H, Xiao J et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007 13 : 486 491.
6. Silvestri P, Di Russo C, Rigattieri S et al. MicroRNAs and ischemic heart disease: towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic targets. Recent Pat Cardiovasc Drug Discov 2009 4 : 109 118.
7. Carè A, Catalucci D, Felicetti F et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007 13 : 613 618.
8. Pedersen IM, Cheng G, Wieland S et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007 449 : 919 922.
9. Poy MN, Eliasson L, Krutzfeldt J et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004 432 : 226 230.
10. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006 103 : 12481 12486.
11. Tsitsiou E, Lindsay MA. microRNAs and the immune response. Curr Opin Pharmacol 2009 9 : 514 520.
12. Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner-Svensson HM, Lindsay MA. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J Immunol 2008 180 : 5689 5698.
13. Lukiw WJ, Zhao Y, Cui JG. An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem 2008 283 : 31315 31322.
14. Williams AE, Perry MM, Moschos SA, Larner-Svensson HM, Lindsay MA. Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem Soc Trans 2008 36 : 1211 1215.
15. Nahid MA, Pauley KM, Satoh M, Chan EK. MICRORNA-146A is critical for endotoxin-induced tolerance. Implication on innate immunity. J Biol Chem 2009 284 : 34590 34599.
16. Jensen LE, Muzio M, Mantovani A, Whitehead AS. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein. J Immunol 2000 164 : 5277 5286.
17. Ye H, Arron JR, Lamothe B et al. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 2002 418 : 443 447.
18. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 2008 27 : 5643 5647.
19. Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 2008 10 : R101.
20. Dai R, Phillips RA, Zhang Y, Khan D, Crasta O, Ahmed SA. Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood 2008 112 : 4591 4597.
21. Hou J, Wang P, Lin L et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. type I. J Immunol 2009 183 : 2150 2158.
22. Bellon M, Lepelletier Y, Hermine O, Nicot C. Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood 2009 113 : 4914 4917.
23. Yoneyama M, Kikuchi M, Natsukawa T et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004 5 : 730 737.
24. Takeuchi O, Akira S. MDA5/RIG-I and virus recognition. Curr Opin Immunol 2008 20 : 17 22.
25. Motsch N, Pfuhl T, Mrazek J, Barth S, Grässer FA. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol 2007 4 : 131 137.
26. Cameron JE, Yin Q, Fewell C et al. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J Virol 2008 82 : 1946 1958.
27. Nakasa T, Miyaki S, Okubo A et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 2008 58 : 1284 1292.
28. Stanczyk J, Pedrioli DM, Brentano F et al. Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 2008 58 : 1001 1009.
29. Sonkoly E, Ståhle M, Pivarcsi A. MicroRNAs: novel regulators in skin inflammation. Clin Exp Dermatol 2008 33 : 312 315.
30. Tang Y, Luo X, Cui H et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009 60 : 1065 1075.
31. Chan EK, Satoh M, Pauley KM. Contrast in aberrant microRNA expression in systemic lupus erythematosus and rheumatoid arthritis: is microRNA-146 all we need? Arthritis Rheum 2009 60 : 912 915.
32. He H, Jazdzewski K, Li W et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 2005 102 : 19075 19080.
33. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A 2008 105 : 7269 7274.
34. Zhang H, Luo XQ, Zhang P et al. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS ONE 2009 4 : e7826.
35. Young LS, Murray PG. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 2003 22 : 5108 5121.
36. Xu T, Zhu Y, Wei QK et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 2008 29 : 2126 2131.
37. Shen J, Ambrosone CB, DiCioccio RA, Odunsi K, Lele SB, Zhao H. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 2008 29 : 1963 1966.
38. Xu B, Feng NH, Li PC et al. A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. Prostate 2009 Nov 9. [Epub ahead of print]
39. Inoue J, Gohda J, Akiyama T, Semba K. NF-kappaB activation in development and progression of cancer. Cancer Sci 2007 98 : 268 274.
40. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 2009 69 : 1279 1283.
41. Eisenberg I, Eran A, Nishino I et al. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci USA 2007 104 : 17016 17021.
42. Vasyutina E, Lenhard DC, Birchmeier C. Notch function in myogenesis. Cell Cycle 2007 6 : 1451 1454.
43. Luo D, Renault VM, Rando TA. The regulation of Notch signaling in muscle stem cell activation and postnatal myogenesis. Semin Cell Dev Biol 2005 16 : 612 622.
44. Kuang W, Tan J, Duan Y et al. Cyclic stretch induced miR-146a upregulation delays C2C12 myogenic differentiation through inhibition of Numb. Biochem Biophys Res Commun 2009 378 : 259 263.
45. Boultwood J, Fidler C, Strickson AJ et al. Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome. Blood 2002 99 : 4638 4641.
46. Starczynowski DT, Kuchenbauer F, Argiropoulos B et al. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat Med 2010 16 : 49 58.
47. Chen X, Ba Y, Ma L et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008 18 : 997 1006.
48. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2009 Oct 28. [Epub ahead of print]
49. Zhu W, Qin W, Atasoy U, Sauter ER. Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes 2009 2 : 89.
50. Shin J, Kayser SR, Langaee TY. Pharmacogenetics: from discovery to patient care. Am J Health Syst Pharm 2009 66 : 625 637.
51. Mishra PJ, Bertino JR. MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics 2009 10 : 399 416.
52. Mishra PJ, Humeniuk R, Mishra PJ, Longo-Sorbello GS, Banerjee D, Bertino JR. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci U S A 2007 104 : 13513 13518.
53. Mishra PJ, Mishra PJ, Banerjee D, Bertino JR. MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: introducing microRNA pharmacogenomics. Cell Cycle 2008 7 : 853 858.